Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 116

1.

Diagnostic Criteria for Parkinson's Disease: From James Parkinson to the Concept of Prodromal Disease.

Marsili L, Rizzo G, Colosimo C.

Front Neurol. 2018 Mar 23;9:156. doi: 10.3389/fneur.2018.00156. eCollection 2018. Review.

2.

Are dementia with Lewy bodies and Parkinson's disease dementia the same disease?

Jellinger KA, Korczyn AD.

BMC Med. 2018 Mar 6;16(1):34. doi: 10.1186/s12916-018-1016-8.

3.

CSF tau and β-amyloid predict cerebral synucleinopathy in autopsied Lewy body disorders.

Irwin DJ, Xie SX, Coughlin D, Nevler N, Akhtar RS, McMillan CT, Lee EB, Wolk DA, Weintraub D, Chen-Plotkin A, Duda JE, Spindler M, Siderowf A, Hurtig HI, Shaw LM, Grossman M, Trojanowski JQ.

Neurology. 2018 Mar 20;90(12):e1038-e1046. doi: 10.1212/WNL.0000000000005166. Epub 2018 Feb 21.

PMID:
29467305
4.

Tau Positron Emission Tomography Imaging in Degenerative Parkinsonisms.

Lyoo CH, Cho H, Choi JY, Ryu YH, Lee MS.

J Mov Disord. 2018 Jan;11(1):1-12. doi: 10.14802/jmd.17071. Epub 2018 Jan 23. Review.

5.

Dementia with Parkinson disease: Clinical diagnosis, neuropsychological aspects and treatment.

Otero JL.

Dement Neuropsychol. 2008 Oct-Dec;2(4):261-266. doi: 10.1590/S1980-57642009DN20400005. Review.

6.

Effects of carbonated liquid on swallowing dysfunction in dementia with Lewy bodies and Parkinson's disease dementia.

Larsson V, Torisson G, Bülow M, Londos E.

Clin Interv Aging. 2017 Aug 8;12:1215-1222. doi: 10.2147/CIA.S140389. eCollection 2017.

7.

Distinct α-Synuclein strains and implications for heterogeneity among α-Synucleinopathies.

Peng C, Gathagan RJ, Lee VM.

Neurobiol Dis. 2018 Jan;109(Pt B):209-218. doi: 10.1016/j.nbd.2017.07.018. Epub 2017 Jul 24. Review.

PMID:
28751258
8.

Structural and Functional Neuroimaging of Visual Hallucinations in Lewy Body Disease: A Systematic Literature Review.

Pezzoli S, Cagnin A, Bandmann O, Venneri A.

Brain Sci. 2017 Jul 15;7(7). pii: E84. doi: 10.3390/brainsci7070084. Review.

9.

Decision-Making Deficits Associated with Amyloidosis in Lewy Body Disorders.

Spotorno N, McMillan CT, Irwin DJ, Clark R, Lee EB, Trojanowski JQ, Weintraub D, Grossman M.

Front Hum Neurosci. 2017 Jan 11;10:693. doi: 10.3389/fnhum.2016.00693. eCollection 2016.

10.

Neuropathological and genetic correlates of survival and dementia onset in synucleinopathies: a retrospective analysis.

Irwin DJ, Grossman M, Weintraub D, Hurtig HI, Duda JE, Xie SX, Lee EB, Van Deerlin VM, Lopez OL, Kofler JK, Nelson PT, Jicha GA, Woltjer R, Quinn JF, Kaye J, Leverenz JB, Tsuang D, Longfellow K, Yearout D, Kukull W, Keene CD, Montine TJ, Zabetian CP, Trojanowski JQ.

Lancet Neurol. 2017 Jan;16(1):55-65. doi: 10.1016/S1474-4422(16)30291-5.

11.
12.

Increased phosphorylation of collapsin response mediator protein-2 at Thr514 correlates with β-amyloid burden and synaptic deficits in Lewy body dementias.

Xing H, Lim YA, Chong JR, Lee JH, Aarsland D, Ballard CG, Francis PT, Chen CP, Lai MK.

Mol Brain. 2016 Sep 8;9(1):84. doi: 10.1186/s13041-016-0264-9.

13.

Reducing Endogenous α-Synuclein Mitigates the Degeneration of Selective Neuronal Populations in an Alzheimer's Disease Transgenic Mouse Model.

Spencer B, Desplats PA, Overk CR, Valera-Martin E, Rissman RA, Wu C, Mante M, Adame A, Florio J, Rockenstein E, Masliah E.

J Neurosci. 2016 Jul 27;36(30):7971-84. doi: 10.1523/JNEUROSCI.0775-16.2016.

14.

Next-generation sequencing reveals substantial genetic contribution to dementia with Lewy bodies.

Geiger JT, Ding J, Crain B, Pletnikova O, Letson C, Dawson TM, Rosenthal LS, Pantelyat A, Gibbs JR, Albert MS, Hernandez DG, Hillis AE, Stone DJ, Singleton AB; North American Brain Expression Consortium, Hardy JA, Troncoso JC, Scholz SW.

Neurobiol Dis. 2016 Oct;94:55-62. doi: 10.1016/j.nbd.2016.06.004. Epub 2016 Jun 14.

15.

C9orf72 Hexanucleotide Repeat Analysis in Cases with Pathologically Confirmed Dementia with Lewy Bodies.

Geiger JT, Arthur KC, Dawson TM, Rosenthal LS, Pantelyat A, Albert M, Hillis AE, Crain B, Pletnikova O, Troncoso JC, Scholz SW.

Neurodegener Dis. 2016;16(5-6):370-2. doi: 10.1159/000445872. Epub 2016 May 31.

16.

Lewy Body Dementias: Dementia With Lewy Bodies and Parkinson Disease Dementia.

Gomperts SN.

Continuum (Minneap Minn). 2016 Apr;22(2 Dementia):435-63. doi: 10.1212/CON.0000000000000309. Review.

17.

Metabolic network expression in parkinsonism: Clinical and dopaminergic correlations.

Ko JH, Lee CS, Eidelberg D.

J Cereb Blood Flow Metab. 2017 Feb;37(2):683-693. doi: 10.1177/0271678X16637880. Epub 2016 Jul 21.

18.

Precision Medicine: Clarity for the Complexity of Dementia.

Cholerton B, Larson EB, Quinn JF, Zabetian CP, Mata IF, Keene CD, Flanagan M, Crane PK, Grabowski TJ, Montine KS, Montine TJ.

Am J Pathol. 2016 Mar;186(3):500-6. doi: 10.1016/j.ajpath.2015.12.001. Epub 2015 Dec 24. Review.

19.

Pathological α-synuclein distribution in subjects with coincident Alzheimer's and Lewy body pathology.

Toledo JB, Gopal P, Raible K, Irwin DJ, Brettschneider J, Sedor S, Waits K, Boluda S, Grossman M, Van Deerlin VM, Lee EB, Arnold SE, Duda JE, Hurtig H, Lee VM, Adler CH, Beach TG, Trojanowski JQ.

Acta Neuropathol. 2016 Mar;131(3):393-409. doi: 10.1007/s00401-015-1526-9. Epub 2015 Dec 31.

20.

PET Radioligands Reveal the Basis of Dementia in Parkinson's Disease and Dementia with Lewy Bodies.

Gomperts SN, Marquie M, Locascio JJ, Bayer S, Johnson KA, Growdon JH.

Neurodegener Dis. 2016;16(1-2):118-24. doi: 10.1159/000441421. Epub 2015 Dec 8.

Supplemental Content

Support Center